# Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)

> **NCT00827983** · PHASE3 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 683 (actual)

## Conditions studied

- In Vitro Fertilization

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT00827983
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-11
- **Final completion:** 2011-05
- **Target enrollment:** 683 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827983, "Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00827983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*